pubmed-article:6978363 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6978363 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:6978363 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:6978363 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:6978363 | lifeskim:mentions | umls-concept:C0221102 | lld:lifeskim |
pubmed-article:6978363 | lifeskim:mentions | umls-concept:C0009498 | lld:lifeskim |
pubmed-article:6978363 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:6978363 | lifeskim:mentions | umls-concept:C0205369 | lld:lifeskim |
pubmed-article:6978363 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:6978363 | lifeskim:mentions | umls-concept:C0376517 | lld:lifeskim |
pubmed-article:6978363 | lifeskim:mentions | umls-concept:C1881379 | lld:lifeskim |
pubmed-article:6978363 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:6978363 | pubmed:dateCreated | 1982-6-14 | lld:pubmed |
pubmed-article:6978363 | pubmed:abstractText | Thymocytes from C57BL/6(B6) mice treated with anti-Thy 1 antiserum without complement in vitro were transferred to lethally irradiated AKR mice. Five days following transfer, the proportion of Thy 1.2(+) cells recovered from the recipient spleen was significantly lower (7%) than that from the control mice which had received untreated cells (64%). the B6 spleen cells were treated in the same manner and transferred with SRBC (T-dependent antigen) or DNP-Ficoll (T-independent antigen) to irradiated syngeneic recipients. The recipients developed a response to SRBC which was significantly lower than that observed in control mice, but showed the same number of plaque-forming cell (PFC) against TNP-SRBC as the control group of mice which had received untreated B6 spleen cells. These results clearly show that in vitro pretreatment of lymphocytes with anti-Thy 1 serum without complement specifically resulted in elimination or inactivation of the T lineage cells in the host environment. The mechanisms of the elimination are discussed in this study. | lld:pubmed |
pubmed-article:6978363 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6978363 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6978363 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6978363 | pubmed:language | eng | lld:pubmed |
pubmed-article:6978363 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6978363 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:6978363 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6978363 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6978363 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6978363 | pubmed:month | Mar | lld:pubmed |
pubmed-article:6978363 | pubmed:issn | 0022-1759 | lld:pubmed |
pubmed-article:6978363 | pubmed:author | pubmed-author:GoodR ARA | lld:pubmed |
pubmed-article:6978363 | pubmed:author | pubmed-author:FernandesGG | lld:pubmed |
pubmed-article:6978363 | pubmed:author | pubmed-author:KakinumaMM | lld:pubmed |
pubmed-article:6978363 | pubmed:author | pubmed-author:MorikawaKK | lld:pubmed |
pubmed-article:6978363 | pubmed:author | pubmed-author:MooeS WSW | lld:pubmed |
pubmed-article:6978363 | pubmed:author | pubmed-author:YasumizuRR | lld:pubmed |
pubmed-article:6978363 | pubmed:author | pubmed-author:Oh-IshiTT | lld:pubmed |
pubmed-article:6978363 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6978363 | pubmed:day | 26 | lld:pubmed |
pubmed-article:6978363 | pubmed:volume | 49 | lld:pubmed |
pubmed-article:6978363 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6978363 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6978363 | pubmed:pagination | 315-22 | lld:pubmed |
pubmed-article:6978363 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:meshHeading | pubmed-meshheading:6978363-... | lld:pubmed |
pubmed-article:6978363 | pubmed:year | 1982 | lld:pubmed |
pubmed-article:6978363 | pubmed:articleTitle | Specific elimination of the T lineage cells: effect of in vitro treatment with anti-Thy 1 serum without complement on the adoptive cell transfer system. | lld:pubmed |
pubmed-article:6978363 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6978363 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:6978363 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6978363 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6978363 | lld:pubmed |